How is DSIP Administered, and What is the Recommended Dosage
doi: 10.1001/jama.2020.9482 169
Call your healthcare provider right away and stop treatment if you get a rash or hives, itching, tightness of the throat, chest pain or tightness, difficulty breathing, lightheadedness, dizziness, nausea or fainting
Additional tirzepatide safety concerns include risk of acute gallbladder disease (presenting as right upper quadrant pain, fever, or jaundice), acute kidney injury from dehydration (especially if severe gastrointestinal symptoms occur), and hypersensitivity reactions
Availability depends on the patients location, medical eligibility, pharmacy capabilities, and applicable federal and state requirements